tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ENFN Stock Latest News

Enfusion, Inc. Reports Strong Q3 2024 Results
Company AnnouncementsEnfusion, Inc. Reports Strong Q3 2024 Results
10h ago
ENFN
Enfusion price target raised to $11 from $10 at Stifel
PremiumThe Fly
Enfusion price target raised to $11 from $10 at Stifel
18h ago
ENFN
Enfusion reports Q3 EPS 5c, consensus 6c
PremiumThe Fly
Enfusion reports Q3 EPS 5c, consensus 6c
1d ago
ENFN
Enfusion narrows FY24 EPS view to $202M-205M, consensus $204.8M
PremiumThe Fly
Enfusion narrows FY24 EPS view to $202M-205M, consensus $204.8M
1d ago
ENFN
ENFN Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ENFN Upcoming Earnings Report: What to Expect?
3d ago
ENFN
Enfusion jumps roughly 11% after report of sale exploration
PremiumThe FlyEnfusion jumps roughly 11% after report of sale exploration
2M ago
ENFN
Enfusion exploring possible sale after receiving takeover interest, Reuters says
Premium
The Fly
Enfusion exploring possible sale after receiving takeover interest, Reuters says
2M ago
ENFN
Enfusion trading resumes
Premium
The Fly
Enfusion trading resumes
2M ago
ENFN
Enfusion trading halted, volatility trading pause
PremiumThe Fly
Enfusion trading halted, volatility trading pause
2M ago
ENFN
Enfusion exploring options, including possible sale, Reuters reports
PremiumThe Fly
Enfusion exploring options, including possible sale, Reuters reports
2M ago
ENFN
Enfusion reports Q2 EPS 5c, consensus 6c
PremiumThe Fly
Enfusion reports Q2 EPS 5c, consensus 6c
3M ago
ENFN
Warner Bros. upgraded, Cerence downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Warner Bros. upgraded, Cerence downgraded: Wall Street’s top analyst calls
6M ago
BAX
MMM
Enfusion assumed with an Overweight at Morgan Stanley
PremiumThe FlyEnfusion assumed with an Overweight at Morgan Stanley
6M ago
ENFN
Enfusion reports Q1 adjusted EPS 6c, consensus 4c
Premium
The Fly
Enfusion reports Q1 adjusted EPS 6c, consensus 4c
6M ago
ENFN
Enfusion to hold an analyst and investor day
Premium
The Fly
Enfusion to hold an analyst and investor day
8M ago
ENFN
Enfusion’s Upcoming Investor Day and Information Disclosure
PremiumCompany Announcements
Enfusion’s Upcoming Investor Day and Information Disclosure
8M ago
8K
ENFN
Enfusion to hold an analyst and investor day
PremiumThe Fly
Enfusion to hold an analyst and investor day
8M ago
ENFN
Enfusion down 3% at $9.00 after short thesis by Spruce Point Capital
PremiumThe Fly
Enfusion down 3% at $9.00 after short thesis by Spruce Point Capital
8M ago
ENFN
Spruce Point short Enfusion, sees 40%-60% long-term downside risk
PremiumThe Fly
Spruce Point short Enfusion, sees 40%-60% long-term downside risk
8M ago
ENFN
Spruce Point short Enfusion, sees 40%-60% long-term downside risk
PremiumThe FlySpruce Point short Enfusion, sees 40%-60% long-term downside risk
8M ago
ENFN
Enfusion price target raised to $9 from $8 at BofA
Premium
The Fly
Enfusion price target raised to $9 from $8 at BofA
8M ago
ENFN
Enfusion sees FY24 revenue $200M-$210M, consensus $202.3M
Premium
The Fly
Enfusion sees FY24 revenue $200M-$210M, consensus $202.3M
8M ago
ENFN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >